Predict your next investment

Private Equity
genes-ventures.de

See what CB Insights has to offer

Investments

3

Funds

5

About GENES

The firm is focused on spin-offs from university and science centers, and industrial R&D based divestitures as target groups.

GENES Headquarter Location

Koelner Strasse 27

Frechen, D-50226,

Germany

49 22 349 55 46 0

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest GENES News

Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast Till 2024 (Updated) Research Report: – Share, Market Size, Revenue Analysis By Each Segment

Feb 16, 2020

The Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report conducts a deep estimation on the present state of CRISPR And CRISPR-Associated (Cas) Genes Industry with the definition, classification and market scope. The fundamental CRISPR And CRISPR-Associated (Cas) Genes Industry aspects like competitive landscape structure, eminent industry players, CRISPR And CRISPR-Associated (Cas) Genes Market size and value is studied. The CRISPR And CRISPR-Associated (Cas) Genes Market growth trends, development plans, dynamic market driving factors and risk assessment is conducted. All the traders, dealers, distributors of Global CRISPR And CRISPR-Associated (Cas) Genes Industry are studied at a global level. The business strategies and plans implemented by top CRISPR And CRISPR-Associated (Cas) Genes Market players are covered in this study. The useful insights into the geographical presence of Global CRISPR And CRISPR-Associated (Cas) Genes Market, revenue analysis, share and market value is explained. To begin with, the introduction, operating nature, product classification, scope and maturity analysis is conducted. The entire top Global CRISPR And CRISPR-Associated (Cas) Genes Industry players and their presence in different regions and countries are evaluated. The development plans, CRISPR And CRISPR-Associated (Cas) Genes growth tactics, and complete industry overview is represented from 2014-2019 and forecast analysis from 2019-2024. Request A Free Sample Report “Global CRISPR And CRISPR-Associated (Cas) Genes Industry Market Research Report” Here: https://www.globalmarketers.biz/report/life-sciences/global-crispr-and-crispr-associated-(cas)-genes-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/131472#request_sample The Top CRISPR And CRISPR-Associated (Cas) Genes Industry Players Are: Caribou Biosciences GE Healthcare Dharmacon The Global CRISPR And CRISPR-Associated (Cas) Genes Industry is segmented based on Applications, Product Category and Research Regions. The top regions & countries analysed in this report are: North America (United States, Canada, Mexico and others) Europe (Germany, France, United Kingdom, Italy, Russia and others) Middle East & Africa (Egypt, Saudi Arabia, Turkey, South Africa, and rest) Southeast Asia (Japan, Korea, India, China, and rest) South America (Brazil, Argentina, Peru, Chile and rest)   The key opinion leaders of Global CRISPR And CRISPR-Associated (Cas) Genes market are interviewed to derive the CRISPR And CRISPR-Associated (Cas) Genes Market size estimation and market numbers. Top regions studied for Global CRISPR And CRISPR-Associated (Cas) Genes Industry presence include North America, Europe, Middle East & Africa, Asia-Pacific with Southeast Asia and South America. On a country level, the CRISPR And CRISPR-Associated (Cas) Genes Market analysis include United States, Canada, Mexico, Brazil, China, Japan, India, Korea, Germany, UK, France, Germany, Russia, Egypt, South Africa, Turkey and the rest. Along with Global CRISPR And CRISPR-Associated (Cas) Genes Market size and value, the demand & supply statistics, utilization volume, gross margin structure and pricing analysis are conducted. Also, the production capacity, existing and emerging segments of Global CRISPR And CRISPR-Associated (Cas) Genes Industry Market, new business plans are featured in this study. The sales price, CRISPR And CRISPR-Associated (Cas) Genes Industry competition is provided. This research study is divided based on CRISPR And CRISPR-Associated (Cas) Genes product type, applications across various industry verticals and research regions for concise understanding. Types Of Global CRISPR And CRISPR-Associated (Cas) Genes Market: Genome Editing Report Will Address The Below Queries: The key factors enhancing the Global CRISPR And CRISPR-Associated (Cas) Genes Industry growth as well as the factors limiting the market growth are evaluated. The development activities in CRISPR And CRISPR-Associated (Cas) Genes industry, market scope, new product releases and mergers & acquisitions are studied deeply. The CRISPR And CRISPR-Associated (Cas) Genes Industry dimensions are conducted based on production volume and market value to evaluate the revenue and growth rate. The upstream raw material suppliers and downstream buyers in Global CRISPR And CRISPR-Associated (Cas) Genes Market comprehensively study. The traders, distributors, dealers and manufacturers involved in CRISPR And CRISPR-Associated (Cas) Genes on a global scale is offered. The SWOT analysis is conducted for every region and Global CRISPR And CRISPR-Associated (Cas) Genes Market players. The industry barriers, risks and analyst opinions are structured. The growth trajectory, business structure, risk assessment and complete Global CRISPR And CRISPR-Associated (Cas) Genes Industry landscape is profiled in this study. The production volume, value and demand analysis will define the market scope. The market stability, CRISPR And CRISPR-Associated (Cas) Genes business plans and policies, and SWOT analysis of the industry players will lead to strategic planning. Top Features Of This Research Report: The segmented market view provides detailed and ease of understating the fundamental CRISPR And CRISPR-Associated (Cas) Genes Market prospects. All the top regions, applications, players and product types are analysed. The executive summary of CRISPR And CRISPR-Associated (Cas) Genes Market covers growth rate, revenue, and production from 2014-2019 and forecast from 2019-2024. CRISPR And CRISPR-Associated (Cas) Genes Market competition is represented by concentration ratio, manufacturing base, capacity and utilization volume. The market share, expansion plans, mergers & acquisitions, and pricing structure is represented. The concise understanding of market trends, drivers, opportunities and threats are portrayed in this report. The market status, historical, present and forecast market situation and risks assessment are conducted. The R&D status, new business plans, sales channel, challenges and emerging CRISPR And CRISPR-Associated (Cas) Genes Market players are profiled in this study. Explore Full Report With Detailed TOC Here @ https://www.globalmarketers.biz/report/life-sciences/global-crispr-and-crispr-associated-(cas)-genes-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/131472#table_of_contents Contact Us:

GENES Investments

3 Investments

GENES has made 3 investments. Their latest investment was in Schmitz+Krieger as part of their Growth Equity on June 6, 2006.

CBI Logo

GENES Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/2006

Growth Equity

Schmitz+Krieger

$1.76M

Yes

1

5/15/2003

Debt

Subscribe to see more

$99M

Subscribe to see more

10

5/15/2003

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/2006

5/15/2003

5/15/2003

Round

Growth Equity

Debt

Growth Equity

Company

Schmitz+Krieger

Subscribe to see more

Subscribe to see more

Amount

$1.76M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

GENES Fund History

5 Fund Histories

GENES has 5 funds, including Pollux.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/30/2003

Pollux

Early-Stage Venture Capital

$5.84M

1

1/1/1991

Oak

Subscribe to see more

$99M

10

1/1/1986

Euroventures Germany

Subscribe to see more

$99M

10

1/1/1983

International Venture Capital Partners

Subscribe to see more

$99M

10

START Early Stage Fund

Subscribe to see more

$99M

10

Closing Date

6/30/2003

1/1/1991

1/1/1986

1/1/1983

Fund

Pollux

Oak

Euroventures Germany

International Venture Capital Partners

START Early Stage Fund

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$5.84M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

GENES Team

3 Team Members

GENES has 3 team members, including current General Partner, Klaus Nathusius.

Name

Work History

Title

Status

Klaus Nathusius

Aurelia Private Equity, and Fidentia Capital

General Partner

Current

Detlev Geiss

General Partner

Former

Erik Hoppe

General Partner

Former

Name

Klaus Nathusius

Detlev Geiss

Erik Hoppe

Work History

Aurelia Private Equity, and Fidentia Capital

Title

General Partner

General Partner

General Partner

Status

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.